Bioinformatics &

Digital Health

Bioinformatics and Digital Health encompass many different fields of application. Continued advancements in bioinformatics are driving forward key developments in precision medicine, placing the patient at the heart of decisions.

We work with innovators in sequencing, genomics, proteomics, metabolomics and cell biology, as well as biosensors and artificial intelligence. We understand the challenges in this area, and can advise you on how to adapt your IP strategy to deal with these.

Our core bioinformatics team includes attorneys whose practice has a strong focus in this field, with backgrounds in bioinformatics/computational biology, biochemistry, electronics, physics and engineering. They form part of a wider multi-disciplinary team that is over 20-strong and made up of scientists and engineers who have deep knowledge and understanding of the variety of technologies and fields that bioinformatics touches.

We have our finger on the pulse of developments in EPO practice in relation to bioinformatics inventions. We have an impressive record of getting seemingly difficult cases through to grant. 

Digital Health innovations can give rise to a number of valuable assets from data to code, designs of user interfaces, new methods and know-how, each of which can be associated with multiple individual IP rights, both registered and unregistered. Our highly skilled legal team works seamlessly alongside our patent experts to help our clients build a strong bundle of IP rights, including copyrights, trade secrets, database rights, designs and patents. Our integrated team approach means that we can be with you all the way and across the whole spectrum of your IP needs, ensuring efficient, joined-up and commercially relevant advice.

Find out more on our Bioinformatics spotlight page.

Patent_Landscape_in_Bioinformatics_and_Digital_Health_Special_Report_2021-2-Compressed

Special Report

Patent Landscape in Bioinformatics and Digital Health: a data-driven analysis

The words "digital health", "data driven" and "AI" have been on everyone's lips and in many headlines in the healthcare and life sciences sectors over the last couple of years. However, navigating this rapidly changing landscape can be challenging for those in charge of managing the IP associated with the innovations underpinning these changes.  

In this Special Report, we set out to collect data on the patent landscape in the fields of bioinformatics and digital health, to see whether the growth we and our clients see in the field is reflected in the data and whether insights can be gained from the data that will assist in designing better, more informed IP strategies.

Read our blogs

UPC Weekly - Opting-out from the UPC: the Who, the When and the Why

UPC Weekly - Opting-out from the UPC: the Who, the When and the Why

by Matthew Naylor

2024 Week 24 It seems like a long time ago now, but from March to May 2023, the “sunrise period” of the UPC was in full swing and European patent firms were busy filing UPC opt-outs. Patent ...

Podcast with Adam Gregory: protecting innovations in the biotech space

Podcast with Adam Gregory: protecting innovations in the biotech space

by Adam Gregory

Adam Gregory joins John Joson Ng on Nucleate Singapore’s Pulse podcast where he highlights success stories from Singapore’s vibrant biotech scene, including Enleofen Bio and Hummingbird Bioscience, ...

How helpful are biological deposits at the EPO?

How helpful are biological deposits at the EPO?

by Eliot Ward

In our article about biological deposits under the Budapest Treaty, we explored the deadlines and formalities for depositing microorganisms so that the deposit can be referenced in a patent ...

UPC Weekly - Three Known Unknowns at the UPC

UPC Weekly - Three Known Unknowns at the UPC

by Matthew Naylor

2024 Week 23 It’s a bit risky to write a blog where you hope it will go out of date quickly. But right now seems a good time to take stock and draw a breath. Here we summarise the most important ...

Mewburn Ellis ranked ‘gold tier’ in IAM Patent 1000: The World’s Leading Patent Practitioners 2024

Mewburn Ellis ranked ‘gold tier’ in IAM Patent 1000: The World’s Leading Patent Practitioners 2024

by Joanna Smith

We are delighted to once again be ranked ‘gold tier’ in IAM Patent 1000: The World’s Leading Patent Practitioners where we are recommended for our expertise in Patent Prosecution and at the European ...

Mewburn Ellis is first European IP firm to earn Great Place To Work Certification™

Mewburn Ellis is first European IP firm to earn Great Place To Work Certification™

by Maria Hall

We are proud to have been officially named as a Great Place To Work™ 2024 by Great Place To Work®, the global authority on workplace culture. This certification proves we have created a great ...

Forward Magazines Overlapping 6-compressed

Mewburn Ellis

FORWARD MAGAZINE

Mewburn Ellis Forward is a biannual publication that celebrates the best of innovation and exploration. Through its pages we hope to inform and entertain, but also to encourage discussion about the most compelling developments taking place in the scientific and entrepreneurial world. Along the way, we’ll engage with the IP challenges that international organisations face every day.